greeksoup/ stock research

Chemours (CC) Q4 FY2022 earnings: revenue $1.3 billion, down 15.0% on the year

Chemours Co. (CC) reported revenue of $1.3 billion for Q4 FY2022, the quarter ended 31 December 2022, down 15.0% on the same quarter a year earlier. Net income was -$97 million, and diluted earnings per share $-0.65. The figures are the company's own, from the 10-K it filed with the SEC on 27 March 2024.

Revenue
$1.3 billion
-15.0% on the year · -24.7% on the quarter
Q1 FY2021Q4 FY2022
Operating margin
-0.7%
13.0% a year earlier
Q1 FY2021Q4 FY2022
Net income
-$97 million
Q1 FY2021Q4 FY2022
Diluted EPS
-$0.65
Q1 FY2021Q4 FY2022

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ4 FY2022Q3 FY2022Q4 FY2021On the quarterOn the yearLast 8 quarters
Revenue1,3381,7771,574-24.7%-15.0%
Cost of revenue1,1371,3451,181-15.5%-3.7%
Gross profit201432393-53.5%-48.9%
Gross margin15.0%24.3%25.0%
Research and development31.032.029.0-3.1%+6.9%
Selling, general and administrative175140157+25.0%+11.5%
Operating income-10.0261204
Operating margin-0.7%14.7%13.0%
Interest expense41.041.044.00.0%-6.8%
Pre-tax income-69.0299300
Income tax28.059.068.0-52.5%-58.8%
Effective tax raten/a19.7%22.7%
Net income-97.0240232
Net margin-7.2%13.5%14.7%
Diluted EPS-$0.65$1.52$1.40
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ4 FY2022Q3 FY2022Q4 FY2021On the quarterOn the yearLast 8 quarters
Operating cash flow160301214-46.8%-25.2%
Capital expenditure67.072.083.0-6.9%-19.3%
Free cash flow93.0229131-59.4%-29.0%
Free cash flow margin7.0%12.9%8.3%
Cash from investing-65.0-74.0422
Cash from financing-190-175-201
Depreciation and amortisation73.072.077.0+1.4%-5.2%
Share-based compensation3.07.011.0-57.1%-72.7%
Buybacks14479.093.0+82.3%+54.8%
Dividends paid37.039.041.0-5.1%-9.8%
Dividend per sharen/a$0.25n/a
Diluted shares, weightedn/a158mn/a
Shares outstanding at period end149m153m161m-3.0%-7.8%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ4 FY2022Q3 FY2022Q4 FY2021On the quarterOn the yearLast 8 quarters
Shareholders' equity1,1071,2841,081-13.8%+2.4%
Non-controlling interestn/a1.01.0
Debt3,6333,5343,749+2.8%-3.1%
Operating lease liabilities198192179+3.1%+10.6%
Finance lease liabilities49.0n/a60.0-18.3%
Other liabilities2,6532,7342,480-3.0%+7.0%
Total liabilities and equity7,6407,7457,550-1.4%+1.2%
Fixed assets3,1713,0713,154+3.3%+0.5%
Goodwill1021021020.0%0.0%
Intangible assets13.0n/a6.0+116.7%
Cash and equivalents1,1021,1671,451-5.6%-24.1%
Receivables509844644-39.7%-21.0%
Inventory1,4041,3211,099+6.3%+27.8%
Other assets1,3391,2401,094+8.0%+22.4%
Total assets7,6407,7457,550-1.4%+1.2%

Questions

What was Chemours' revenue in Q4 FY2022?

Chemours (CC) reported revenue of $1.3 billion for Q4 FY2022, the quarter ended 31 December 2022, down 15.0% on the same quarter a year earlier.

How much did Chemours earn in Q4 FY2022?

Net loss for Q4 FY2022 was $97 million, and the diluted loss per share $0.65.

When did Chemours report Q4 FY2022 results?

Chemours filed its 10-K for the quarter ended 31 December 2022 with the SEC on 27 March 2024.

Quarterly results, the last 20 quarters

Q3 FY2021Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022Q1 FY2023 †Q2 FY2023 †Q3 FY2023 †Q4 FY2023 †Q1 FY2024 †Q2 FY2024 †Q3 FY2024 †Q4 FY2024 †Q1 FY2025 †Q2 FY2025 †Q3 FY2025 †Q4 FY2025Q1 FY2026Q2 FY2026
Revenue1,6801,5741,7641,9151,7771,3381,5491,6601,5011,3681,3621,5541,5081,3591,3681,6151,4951,3291,3811,591
Cost of revenue1,2531,1811,2781,4181,3451,1371,1811,2501,2281,1131,0781,2461,2221,0941,1321,3371,2621,1741,1691,305
Gross profit427393486497432201368410273247284308286265236278233155212286
Gross margin25%25%28%26%24%15%24%25%18%18%21%20%19%19%17%17%16%12%15%18%
R&D27.029.030.025.032.031.026.028.028.026.028.026.029.026.027.028.026.027.026.027.0
SG&A124157141254140175124779165222137154137170123424122n/a147469
Operating income273204304217261-10.0202-396-46.0-7.011512519.061.053.0-19281.0-6.026.0-213
Operating margin16%13%17%11%15%-1%13%-24%-3%-1%8%8%1%4%4%-12%5%-0%2%-13%
Interest expense45.044.041.040.041.041.042.048.055.063.063.066.068.066.066.067.068.068.069.068.0
Pre-tax income231300280231299-69.0173-43313.0-71.070.069.0-32.01.00.0-24838.0-67.0-22.0-1.0
Tax rate7%23%16%13%20%n/a16%n/a8%n/a23%13%n/a1200%n/an/a-21%n/an/an/a
Net income214232234201240-97.0145-37612.0-18.054.060.0-32.0-11.0-5.0-38046.0-47.0-29.0-274
Net margin13%15%13%10%14%-7%9%-23%1%-1%4%4%-2%-1%-0%-24%3%-4%-2%-17%
Diluted EPS$1.27$1.40$1.43$1.26$1.52-$0.65$0.96-$2.52$0.08-$0.12$0.36$0.39-$0.22-$0.05-$0.03-$2.53$0.40-$0.31-$0.19-$1.81
Operating cash flow3112142.0291301160-12461.0130484-290-620139138-11293.0146137-44.0158
Capital expenditure67.083.010662.072.067.091.058.086.013510273.076.010984.043.041.045.049.044.0
Free cash flow244131-10422922993.0-2153.044.0349-392-69363.029.0-19650.010592.0-93.0114
Buybacks67.093.014412879.014414.037.018.00.0n/an/an/an/an/an/an/an/an/an/a
Dividends paid41.041.040.038.039.037.037.038.037.037.037.037.038.036.037.013.013.015.013.013.0
Shares outstanding164m161m157m156m153m149m149m148m148m149m149m149m149m149m150m150m150m150m150m150m
Filing10-Q10-K10-Q10-Q10-Q10-K10-K10-K10-K10-K10-Q10-Q10-Q10-K10-Q10-Q10-K10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 31 December 2022, filed 27 March 2024: the filing.